Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the third quarter of 2003. Nymox reported a net loss for the quarter ended September 30, 2003 of $847,163, or $0.04 per share, versus a net loss of $799,681, or $0.04 per share in the same period one your ago. For the nine months ending June 30, 2003, Nymox reported a net loss of $2,898,542, or $0.12 per share, compared to $2,526,276, or $0.11 per share for the same period in 2002. The weighted average number of common shares outstanding at September 30, 2003 was 23,496,559, compared to 22,574,262 at September 30, 2002. Product sales in the third quarter of 2003 were $58,416 compared to $70,841 for the third quarter in 2002.
